When was BioDimension founded?

BioDimension was founded in 2021 and raised its 1st funding round 3 years after it was founded.

Where is BioDimension located?

BioDimension is headquartered in Bengaluru, India. It is registered at 4/277, MARIAMMAN KOIL STREET MEL MAYIL ROAD, KV KUPPAM,KATPADI, Vellore, VELLORE, Tamil Nadu, India, 632201.

Who is the current CEO of BioDimension?

Manoj Kumar Sampath of BioDimension.

Which legal entities is BioDimension associated with?

BioDimension is associated with BIODIMENSION TECHNOLOGY PRIVATE LIMITED.

How many employees does BioDimension have?

As of Sep 30, 2026, the latest employee count at BioDimension is 21.

Is BioDimension a funded company?

BioDimension is a funded company, having raised a total of $983K across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 16, 2024.

How much is BioDimension worth?

The latest valuation of BioDimension is ₹***** as of Jun 11, 2026.

When was the latest funding round of BioDimension?

BioDimension's latest funding was a $***** Seed round on Jun 11, 2026, with participation from 2 investors. Its primary sector is Life Sciences Platforms and Tools. Globally, the Life Sciences Platforms and Tools sector has seen $2.36B in funding in 2026 to date.

What is the annual revenue of BioDimension?

Annual revenue of BioDimension is less than ₹10 Cr as on Mar 31, 2025

Where does BioDimension rank among its competitors?

BioDimension ranks 77th amongst 531 active competitors, of which 170 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was BioDimension, which secured $839K in Jun, 2026.

Who are the top competitors of BioDimension?

BioDimension's top competitors include MedGenome, Biocytogen and Personalis. Among them, BioDimension secured the most recent funding round in June, 2026.

BioDimension - 2026 Company Profile, Team, Funding, Competitors & Financials

BioDimension is a seed company based in Bengaluru (India), founded in 2021 by Manoj Kumar Sampath, Pradeep Arunachalam and Ranjith Kumar Velusamy. It operates as a Developer of biofabricating human tissues and organoids to make research. BioDimension has raised $983K in funding from Campus Angels Network and IAN Group, with a current valuation of ₹*****. The company has 531 active competitors, including 170 funded and 83 that have exited. Its top competitors include companies like MedGenome, Biocytogen and Personalis.

Company Details

Developer of biofabricating human tissues and organoids to make research. It is offering biofabricated human tissues as an efficient animal alternative testing solutions to pharma companies for more efficient drug screening and toxicity testing. It leverage biofabrication technology to develop our 3D biofabricated human tissue models.

Website: biodimension.in
Social
Email ID: *****@biodimension.in
Phone Number: +91 **********
Registered Address: 4/277, MARIAMMAN KOIL STREET MEL MAYIL ROAD, KV KUPPAM,KATPADI, Vellore, VELLORE, Tamil Nadu, India, 632201

Key Metrics

Founded Year

2021

Location

Bengaluru, India

Stage

Seed

Total Funding

$983K in 2 rounds

Latest Funding Round

Seed, Jun 11, 2026, $*****

Post Money Valuation

₹***** as on Jun 11, 2026

Investors

Campus Angels Network & 2 more

Ranked

77^th among 531 active competitors

Annual Revenue

0 - ₹10 Cr as on Mar 31, 2025

Employee Count

21 as on Sep 30, 2026

Similar Companies

Pandorum & 77 more

View BioDimension's full profile

BioDimension is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
BIODIMENSION TECHNOLOGY PRIVATE LIMITED CIN: U74999TN2021PTC140662 , India, Active	Jan 09, 2021	0 - ₹10 Cr (As on Mar 31, 2025)	-

BioDimension has raised a total funding of $983K over 2 rounds. Its first funding round was on Oct 16, 2024. Its latest funding round was a Seed round on Jun 11, 2026 for $*****. 2 investors participated in its latest round. BioDimension has 3 institutional investors.

Here is the list of recent funding rounds of BioDimension:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 11, 2026	5849449	Seed	7614740	6635917	8616710	5084155
Oct 16, 2024	7663934	Seed	1584849	8016081	Campus Angels Network	8165014

Access funding benchmarks and valuations. Sign up today!

View details of BioDimension's funding rounds and investors

The founders of BioDimension are Manoj Kumar Sampath, Pradeep Arunachalam and Ranjith Kumar Velusamy. Manoj Kumar Sampath is the CEO of BioDimension.

Here are the details of BioDimension's key team members:

Manoj Kumar Sampath: Co-Founder & CEO of BioDimension.
Contact Info: 1 email address
Pradeep Arunachalam: Co-Founder & CXO of BioDimension.
Contact Info: 1 email address
Ranjith Kumar Velusamy: Co-Founder & Chief Business Officer of BioDimension.
Contact Info: 1 email address

View details of BioDimension's Founder profiles and Board Members

BioDimension's employee count trend

BioDimension has 21 employees as of Sep 26. Here is BioDimension's employee count trend over the years:

Uncover BioDimension's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BioDimension include MedGenome, Biocytogen and Personalis. Here is the list of Top 10 competitors of BioDimension, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	MedGenome 2013, Bengaluru (India), Series E	Provider of DNA sequencing, bioinformatics, and multiomics services	$264M	Novo Holdings, Peak XV Partners & 30 others	70/100
2nd	Biocytogen 2008, Wakefield (United States), Public	Provider of integrated solutions for next-generation antibody drug development	$301M	CMB International Capital, SDIC & 11 others	69/100
3rd	Personalis 2011, Menlo Park (United States), Acquired	Provider of genomic sequencing and diagnosis software for the healthcare industry	$87.3M	Abingworth, Lightspeed Venture Partners & 5 others	68/100
4th	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Coatue & 19 others	67/100
5th	Aspen Neuroscience 2018, San Diego (United States), Series C	Provider of genomic-based personalised pluripotent stem cell therapy	$339M	Revelation Partners, Orbimed & 22 others	67/100
6th	Applied StemCell 2008, Milpitas (United States), Acquired	Provider of animal and cell line models as tools for drug discovery and diagnostics	$67.5M	Fosun, Advantech Capital & 8 others	66/100
7th	Pandorum 2011, Bengaluru (India), Series B	Developer of regenerative medicine and 3D tissues	$52.1M	IAN Group, BTB Venture & 89 others	65/100
8th	InSphero 2009, Schlieren (Switzerland), Series D	Developer of cell based assays for drug screening	$35M	Venturelab, Redalpine & 8 others	64/100
9th	Blue Rock Therapeutics 2016, Boston (United States), Acquired	Stem cell therapies for cardiovascular and neurological diseases	$225M	Versant Ventures, Leaps by Bayer & 1 others	64/100
10th	Exosome Diagnostics 2008, Boston (United States), Acquired	Developer of blood-based cancer molecular diagnostics for patient stratification and disease monitoring	$119M	Forbion, NGN Capital & 7 others	62/100
77th	BioDimension 2021, Bengaluru (India), Seed	Developer of biofabricating human tissues and organoids to make research	$983K	IAN Group, BIRAC & 1 others	46/100